2-85545425-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000821.7(GGCX):​c.*4509G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.514 in 152,128 control chromosomes in the GnomAD database, including 21,099 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.51 ( 21084 hom., cov: 32)
Exomes 𝑓: 0.46 ( 15 hom. )

Consequence

GGCX
NM_000821.7 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.876

Publications

23 publications found
Variant links:
Genes affected
GGCX (HGNC:4247): (gamma-glutamyl carboxylase) This gene encodes an integral membrane protein of the rough endoplasmic reticulum that carboxylates glutamate residues of vitamin K-dependent proteins to gamma carboxyl glutamate, a modification that is required for their activity. The vitamin K-dependent protein substrates have a propeptide that binds the enzyme, with carbon dioxide, dioxide, and reduced vitamin K acting as co-substrates. Vitamin K-dependent proteins affect a number of physiologic processes including blood coagulation, prevention of vascular calcification, and inflammation. Allelic variants of this gene have been associated with pseudoxanthoma elasticum-like disorder with associated multiple coagulation factor deficiency. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]
MAT2A (HGNC:6904): (methionine adenosyltransferase 2A) The protein encoded by this gene catalyzes the production of S-adenosylmethionine (AdoMet) from methionine and ATP. AdoMet is the key methyl donor in cellular processes. [provided by RefSeq, Jun 2011]
MAT2A Gene-Disease associations (from GenCC):
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 2-85545425-C-T is Benign according to our data. Variant chr2-85545425-C-T is described in ClinVar as [Benign]. Clinvar id is 337179.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.679 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GGCXNM_000821.7 linkc.*4509G>A 3_prime_UTR_variant Exon 15 of 15 ENST00000233838.9 NP_000812.2 P38435-1
MAT2ANM_005911.6 linkc.*1653C>T downstream_gene_variant ENST00000306434.8 NP_005902.1 P31153-1A0A140VJP5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GGCXENST00000233838.9 linkc.*4509G>A 3_prime_UTR_variant Exon 15 of 15 1 NM_000821.7 ENSP00000233838.3 P38435-1
MAT2AENST00000306434.8 linkc.*1653C>T downstream_gene_variant 1 NM_005911.6 ENSP00000303147.3 P31153-1

Frequencies

GnomAD3 genomes
AF:
0.514
AC:
78047
AN:
151850
Hom.:
21044
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.685
Gnomad AMI
AF:
0.459
Gnomad AMR
AF:
0.423
Gnomad ASJ
AF:
0.401
Gnomad EAS
AF:
0.390
Gnomad SAS
AF:
0.391
Gnomad FIN
AF:
0.457
Gnomad MID
AF:
0.440
Gnomad NFE
AF:
0.465
Gnomad OTH
AF:
0.506
GnomAD4 exome
AF:
0.456
AC:
73
AN:
160
Hom.:
15
Cov.:
0
AF XY:
0.480
AC XY:
49
AN XY:
102
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.462
AC:
73
AN:
158
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AF:
0.00
AC:
0
AN:
2
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.520
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.514
AC:
78143
AN:
151968
Hom.:
21084
Cov.:
32
AF XY:
0.510
AC XY:
37908
AN XY:
74264
show subpopulations
African (AFR)
AF:
0.685
AC:
28394
AN:
41438
American (AMR)
AF:
0.422
AC:
6441
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.401
AC:
1390
AN:
3466
East Asian (EAS)
AF:
0.390
AC:
2016
AN:
5168
South Asian (SAS)
AF:
0.391
AC:
1888
AN:
4824
European-Finnish (FIN)
AF:
0.457
AC:
4813
AN:
10524
Middle Eastern (MID)
AF:
0.449
AC:
132
AN:
294
European-Non Finnish (NFE)
AF:
0.465
AC:
31576
AN:
67956
Other (OTH)
AF:
0.508
AC:
1074
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1841
3682
5522
7363
9204
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
678
1356
2034
2712
3390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.500
Hom.:
2558
Bravo
AF:
0.518
Asia WGS
AF:
0.439
AC:
1530
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Vitamin K-dependent clotting factors, combined deficiency of, type 1 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.42
DANN
Benign
0.46
PhyloP100
-0.88
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7605975; hg19: chr2-85772548; API